New updates have been reported about Hyro.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Hyro has entered a strategic partnership with Five9 to embed its healthcare-focused AI agents into the Five9 Intelligent Cloud Contact Center, positioning the company at the core of automated patient engagement for health systems. By joining Five9’s AI Agent Connect program as an Accredited ISV partner, Hyro can now plug its agentic AI directly into existing contact-center infrastructure, sharply shortening integration timelines and expanding its addressable market among healthcare providers.
The company is currently the only healthcare-specific vendor accredited in Five9’s program, giving Hyro a differentiated channel to deliver out-of-the-box support for complex clinical and operational workflows such as prescription management, triage and appointment scheduling. Hyro reports that its implementations can now move from the typical two-week integration cycle to potentially a single one-hour meeting, with average deployments of sophisticated voice solutions in under 100 days, enabling faster realization of operational savings and improved patient experience.
Hyro’s leadership positions this alliance as a force multiplier for its Responsible AI Agent Platform, which is already used by major health systems including Intermountain Health, Baptist Health and Hackensack Meridian Health. By leveraging Five9’s installed base of contact-center customers, Hyro can scale its HIPAA-compliant, healthcare-native agents across call centers, websites, SMS and mobile applications, creating a broader data and revenue funnel from patient interactions.
The partnership also reinforces Hyro’s strategic focus on interoperability, a critical requirement for health systems seeking to modernize digital front doors without overhauling legacy infrastructure. Executives at both companies emphasize that clients no longer need to choose between a generic omnichannel contact-center platform and industry-specific AI, as the joint solution is designed to deliver both high configurability and tight alignment to healthcare workflows.
For Hyro, the commercial implications include deeper integration into core patient access operations, higher switching costs for customers and potential upsell opportunities as providers expand automation use cases beyond initial deployments. In a market where health systems are under pressure to cut costs while improving access, the ability to stand up AI-driven patient interactions in hours rather than weeks could translate into faster sales cycles and stronger competitive positioning.
Looking forward, the partnership may also give Hyro richer insight into contact-center performance and patient behavior, enhancing its ability to refine models, deliver analytics and offer value-added services. While financial terms were not disclosed, the Five9 relationship effectively positions Hyro as a preferred healthcare AI layer atop a leading CX platform, aligning with broader industry trends toward specialized, compliant AI agents embedded within mainstream enterprise infrastructure.